ライフサイエンスコーパス: daily

1 ily followed by 8 weeks of 150 mg vismodegib daily).

2 nd a predicted low clinical dose (2 mg twice daily).

3 plementation (60 mg iron as ferrous fumarate daily).

4 e 12 or 16 weeks of G/P (300 mg/120 mg) once daily.

5 mouth with prednisone, 5 mg, by mouth twice daily.

6 ositive IMT received crizotinib orally twice daily.

7 jects continued on 4000 mg of peanut protein daily.

8 to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 pati

9 Only 8% monitored their blood glucose levels daily, 15% monitored weekly, and 10% reported checking t

10 to assess the efficacy and safety of a once-daily, 2-direct-acting-antiviral-agent (2-DAA) combinati

11 r of INCS on demand (30%) compared with INCS daily (22%), that is 8% difference (95% CI -5 to +21%; n

12 l fields, and land use variables to estimate daily 24 h averaged ground-level PM2.5 concentrations ov

13 before challenge, volunteers began a thrice-daily, 7-day course of investigational product administe

14 les were randomized to receive either single daily 80 mg doses of CPP-115 (n=4) or placebo (n=2) for

15 egulation of photosynthesis, and in turn the daily accumulation of sugars from photosynthesis also fe

16 dependent associations between time spent in daily activities and children's physical and mental heal

17 Although of critical importance for our daily activities, little is known about the mechanisms d

18 ry bowel disease (IBD) report impairments in daily activities, social interactions and coping.

19 and increasingly reported problems in basic daily activities.

20 Daily activity is a measure of HF-related and global fun

21 than choreoathetosis, with a major effect on daily activity, quality of life, and societal participat

22 a could be determined for BCVA necessary for daily activity.

23 Median daily ammonium excretion was 19.5 (95% confidence interv

24 (0) or all (1) of the deaths attributable in daily analyses being displaced by at least 1 y.

25 eaths found attributable to heat and cold in daily analyses were brought forward by at least 1 y.

26 d 10% reported checking their blood pressure daily and 43% took their medications as prescribed.

27 ted differences in 5-y absolute risk between daily and non-consumers were 1.9%, 1.1%, and 5.4%, respe

28 imilar between women taking </=5 mg warfarin daily and women treated with LMWH.

29 trial of the effects of atorvastatin (80 mg daily) and subcutaneous evolocumab (420 mg every 2 weeks

30 mg twice daily) plus omeprazole (20 mg once daily), and either rifaximin-EIR (400 mg) or placebo, tw

31 pidermis and its appendages are subjected to daily assaults from the external environment.

32 (DTT) analytical system was used to measure daily average OP (OP(DTT)) in water-soluble fine PM at a

33 ek, and lastly to both weekly adalimumab and daily azathioprine.

34 r for each city and covered each system on a daily basis.

35 with at least 100,000 lesions per cell on a daily basis.

36 However, daily blood product use is difficult to anticipate.

37 anges were associated with the proportion of daily breast milk intake in a dose-dependent manner, eve

38 urve and maximum plasma concentration on the daily, but not intermittent, schedules.

39 Abiraterone acetate, 1000 mg, once daily by mouth with prednisone, 5 mg, by mouth twice dai

40 e fed a Western diet (WD) +/-75 mg PDX twice daily by oral gavage for 14 days.

41 Daily C assimilation was greater at elevated [CO2 ] in b

42 older with PAD were randomized to receive a daily capsule of resveratrol, 125 mg or 500 mg, or place

43 ms are biological oscillations that schedule daily changes in physiology.

44 forcing) and that forecasts generated using daily climatological humidity forcing generally outperfo

45 CK II risk score can be easily calculated in daily clinical practice and strongly correlated with mor

46 were monitored in an outpatient setting with daily clinical review and collection of blood and stool

47 After repeated, but not single, daily cocaine injections, t-LTP in layer V pyramidal neu

48 ventilation in 36 intensive care units, with daily collection of ventilation and weaning modalities.

49 The primary end point was daily combined symptom-medication scores during the 2013

50 The mean daily concentration of PM1 in all cities was 42.5 mug/m(

51 We used source apportionment to estimate daily concentrations of primary source-specific PM2.5 fo

52 erein, we investigated the effect of chronic daily consumption of canola oil on the phenotype of a mo

53 lts from this study provide support that the daily consumption of cashews, when substituted for a hig

54 In this epidemiological study, we collected daily counts of emergency hospital visits from the 28 la

55 ts, those who smoked more than 20 cigarettes daily, current marijuana users, and those who reported 1

56 f ability to open stomata in anticipation of daily dark-to-light changes and of circadian-mediated st

57 alf their standard TKI dose (imatinib 200 mg daily, dasatinib 50 mg daily, or nilotinib 200 mg twice

58 of death, and examined its association with daily deaths in the Boston, Massachusetts, area.

59 the combination of absolute need, uncertain daily demand, and short shelf life, platelet products ar

60 h HF who completed versus did not complete a daily diary of weight and symptom self-assessment and to

61 ng, and gastroparesis cardinal symptom index-daily diary scores of 2.6 or more.

62 in recent years, polar bears covered greater daily distances either by increasing their time spent ac

63 the risk of glaucoma varies depending on the daily dosage or type of statin taken.

64 The 10-year average daily dose from individual and multivitamin supplements

65 IV-1 RNA were similar for the 40-120 mg once-daily dose groups regardless of baseline Gag polymorphis

66 of Bruton's tyrosine kinase (BTK), at a once-daily dose of 420 mg achieved BTK active-site occupancy

67 s seen by day 8 in most patients receiving a daily dose of 80 mg or higher.

68 ds (ie, two capsules a day providing a total daily dose of 800 mg docosahexaenoic acid and 225 mg eic

69 Treatment with a 50-mg once-daily dose of opicapone was associated with a significan

70 Venetoclax monotherapy at a daily dose up to 1200 mg has an acceptable safety profil

71 P = 0.002), especially for users with higher daily doses (HR, 0.54; 95% CI, 0.35-0.83; P = 0.005).

72 not take at least 16 of 21 prescribed total daily doses in cycle 1 because of toxicities attributabl

73 armustine applied once in combination with 2 daily doses of 120 mg/m2 of O6-benzylguanine.

74 However, daily dosing activated atrophic pathways, including F-bo

75 cognitive deficits, these data suggest that daily dosing may be critical to allow for development of

76 ed, double-masked trials reported here, once-daily dosing of netarsudil 0.02% was found to be effecti

77 -life of 12-48 h is generally ideal for once daily dosing of oral drugs.

78 in exposure, indicating that brief pulses of daily drug treatment may be sufficient for long-term eff

79 ravir 30 mg tablets or matching placebo once daily during a 4 week oral lead-in phase, followed by a

80 (95% CI 2.05-6.79) and 5.05% (2.23-7.75) of daily emergency hospital visits in China could be attrib

81 (CRP), albumin, the nutritional risk index, daily energy intake, energy balance (equal to daily ener

82 aily energy intake, energy balance (equal to daily energy intakes minus the REE), and survival were r

83 g friends, with data on the network ties and daily exercise patterns of approximately 1.1M individual

84 Daily exposure of differentiated adipocytes to blue ligh

85 High vs. low daily FA intake was dichotomized at 800mug (median).

86 biogeochemical cycling and contribute to the daily flux of billions of tons of organic matter.

87 eks, then three rounds of 8 weeks of placebo daily followed by 12 weeks of 150 mg vismodegib daily) o

88 eks, then three rounds of 8 weeks of placebo daily followed by 8 weeks of 150 mg vismodegib daily).

89 ard-dose subcutaneous enoxaparin (40 mg once daily for 10+/-4 days) for venous thromboprophylaxis.

90 100, 300, 450, 600, or 900 mg latiglutenase daily for 12 or 24 weeks.

91 to receive either BOS 2 mg or placebo twice daily for 12 weeks.

92 Rapamycin was administered intraperitoneally daily for 14 days at 0.5 mg/kg or 2.5 mg/kg.

93 dy to assess the effect of 1200 mg of gammaT daily for 14 days on sputum eosinophils, mucins, and cyt

94 her rifaximin-EIR (400 mg) or placebo, twice daily for 14 days.

95 nts applied blindly at the investigator site daily for 14 days: pimecrolimus, betamethasone dipropion

96 mivudine 300 mg, with matching placebo, once daily for 144 weeks.

97 , 200 mg IV every 2 weeks, pomalidomide 4 mg daily for 21 days, and dexamethasone 40 mg weekly.

98 daily or decitabine 20 mg/m(2) intravenously daily for 3 consecutive days on a 28-day cycle.

99 xtended-duration oral betrixaban (80 mg once daily for 35-42 days) or standard-dose subcutaneous enox

100 received HBIG 5000 IU in anhepatic phase and daily for 5 days together with nucleos(t)ide analogues i

101 ion therapy or oseltamivir monotherapy twice daily for 5 days, given orally, and participants were fo

102 symptoms and overall symptoms were measured daily for 7 days before the study period; along with sto

103 All subjects received 40 mg of rosuvastatin daily for 8 to 12 weeks, when the nonculprit lesion was

104 placebo or 25 mg spironolactone (usual care) daily for 96 hours.

105 ve concurrent pyridoxine (200 mg) or placebo daily for a maximum of 8 cycles of capecitabine, with st

106 support the use of raltegravir 1200 mg once daily for first-line therapy.

107 Patients were assessed daily for postoperative delirium (primary outcome) and s

108 tinib 50 mg daily, or nilotinib 200 mg twice daily) for 12 months.

109 by clemastine fumarate (5.36 mg orally twice daily) for 60 days (group 2).

110 er clemastine fumarate (5.36 mg orally twice daily) for 90 days followed by placebo for 60 days (grou

111 We compared a new once daily formulation of raltegravir to the currently market

112 raltegravir to the currently marketed twice daily formulation.

113 al data regarding age, sex, and duration and daily frequency of smoking were gathered using a questio

114 Fasting venous ammonia levels were estimated daily from 0 to 5 days.

115 Sleep apnea is a common problem affecting daily functioning and health.

116 function that lead to differences in average daily gain (ADG), rumen fluid metabolomic analysis by LC

117 orporated well phase, location, total depth, daily gas production and inverse distance-squared to pat

118 timated these contagion effects by combining daily global weather data, which creates exogenous varia

119 y group versus 25 months (21-31) in the once-daily group (hazard ratio for death in the once daily gr

120 in 130 (24%) of 531 participants in the once daily group (one of which was serious; none led to treat

121 nd 68 (26%) of 266 participants in the twice daily group (two of which were serious; two led to treat

122 ly group (hazard ratio for death in the once daily group 1.18 [95% CI 0.95-1.45]; p=0.14).

123 treatment-related causes (three in the twice-daily group and eight in the once-daily group).

124 al was 30 months (95% CI 24-34) in the twice-daily group versus 25 months (21-31) in the once-daily g

125 the twice-daily group and eight in the once-daily group).

126 Daily habits remained relatively stable across time from

127 Dabigatran (150 mg twice daily) has been associated with lower rates of stroke th

128 t the inclusion of this functional food in a daily human diet could contribute to improve consumers'

129 Furthermore, daily i.p. injection of SR3306 (7 days) prevented the in

130 ice learned new sets of three goal locations daily in a multiwell maze.

131 Apixaban 2.5 mg twice daily in patients on hemodialysis resulted in drug expos

132 OXT treatment (24 International Units, twice daily) in 32 children with ASD, aged 6-12 y.

133 e with that of the standard dose (5 mg twice daily) in patients with preserved renal function and mig

134 ly (previously known as LCZ696 [200 mg twice daily]) in addition to guideline-directed medical therap

135 ticosteroids were randomised to receive once daily, inhaled budesonide 400 mug (those aged <11 years

136 caemic outcomes when switching from multiple daily injections (MDI) to CSII in adults with type 1 dia

137 ntestine-specific knockout of FXR were given daily injections of fibroblast growth factor (FGF)19.

138 Daily injections of insulin provide lifesaving benefits

139 ults with type 2 diabetes receiving multiple daily injections of insulin.

140 Our recent work showed that daily injections of osteoprotegerin (OPG)-immunoglobulin

141 ration of bictegravir, a novel, potent, once-daily INSTI designed to improve on existing INSTI option

142 et or oral antidiabetic drugs or had a total daily insulin dose of 0.6 units per kg or less, admitted

143 with type 1 diabetes who were using multiple daily insulin injections and had hemoglobin A1c (HbA1c)

144 insulin pump therapy or with multiple (>/=4) daily insulin injections.

145 orders of magnitude lower than the tolerable daily intake (TDI) reported by the European Food Safety

146 Daily intake estimation comparisons through diet diary a

147 ) were statistically significant for average daily intake mg/d of total THMs [OR=1.53 (95% CI: 1.01,

148 r, most women do not receive the recommended daily intake of folate from diet alone.

149 nalysis of duplicate diets, with a mean+/-sd daily intakes of 956+/-327.9mg estimated from diet diary

150 s [infrequent], or >/=3 days [frequent]) and daily intensity of smoking and vaping (number of cigaret

151 o samples of natural speech sampled from the daily interactions of 143 healthy adults, both total lan

152 The intradermal arm tested daily intradermal injection of gentamicin solution (8 mg

153 Daily intranasal treatment of wild-type mice with C3a be

154 The Daily Inventory of Stressful Events assessed prior day s

155 INTERPRETATION: Daily iodine supplementation in mildly iodine-deficient

156 who cooked with the iron ingot or consumed a daily iron supplement compared with a control after 1 y.

157 MN, Fe+MMN, and placebo groups, respectively.Daily iron supplementation for 12 wk increased hemoglobi

158 Each strain was tested for 10 daily IVSA sessions.

159 Apixaban 5 mg twice daily led to supratherapeutic levels in patients on hemo

160 These aspects of daily life are known to be impaired after extended wake,

161 ntation), depending on residual arm usage in daily life to substitute for the missing hand's function

162 In our daily life, we rapidly and flexibly retrieve a host of b

163 Our daily-life actions are typically driven by vision.

164 conditions improved verbal communication in daily-life situations in people with chronic aphasia aft

165 l impairment and impairment in activities of daily living (ADL) (defined as severe or moderate to sev

166 Frailty, activities of daily living (ADL)/instrumental ADL (IADL) disability, C

167 erate to severe limitations in activities of daily living (clinical functional score >/=2) should use

168 iodical clinical reassessment, activities of daily living and care management.

169 socioeconomics might compress activities of daily living disability, that is, benefits of success, b

170 iated with disability in basic activities of daily living or with cognition.

171 [CI], -175 to -43), London Chest Activity of Daily Living Questionnaire = 18 (95% CI, 7-30), and St.

172 ns, psychosocial function, and activities of daily living were pooled separately for mild cognitive i

173 men's functional capacities in activities of daily living, cognition, and physical performance were w

174 iated with deletion carriers indicated worse daily living, communication, and social skills compared

175 chronic diseases and impaired activities of daily living, faster walking speed, and favorable object

176 d 16% had difficulty with >/=1 activities of daily living.

177 atients to ASA alone, ticagrelor 60 mg twice daily + low-dose ASA, or ticagrelor 90 mg twice daily +

178 ly + low-dose ASA, or ticagrelor 90 mg twice daily + low-dose ASA.

179 ical model to predict June-July-August (JJA) daily maximum 8-h average (MDA8) ozone concentrations in

180 te a decrease in daily maximum temperatures, daily maximum boundary layer heights, and ventilation co

181 rological simulations indicate a decrease in daily maximum temperatures, daily maximum boundary layer

182 We generated current and future daily mean temperature series under four scenarios of cl

183 By recording over 250,000 daily measurements for up to 43 individuals, we found pe

184 dermal treatment group, as measured based on daily (median difference, 35; 95% CI, 4.0-67.5; P = .03)

185 t depend greatly on the disutility caused by daily medication use (pill burden).

186 ted a genome-wide association study of usual daily methadone dose.

187 e expression and one of the planet's largest daily migrations of biomass.

188 sufficient evidence to support referring or daily monitoring of children with chest indrawing pneumo

189 F), a fortified corn-soy blend (CSB+) with a daily multiple micronutrient antenatal supplement [Unite

190 dence interval (CI): 1.39-6.19) minutes more daily MVPA than other participants.

191 ) and ozone, and at levels below the current daily NAAQS, and mortality in the continental United Sta

192 llations were suppressed consistently across daily nicotine treatments.

193 iofi alla romana showed to contribute to the daily nutritional recommendations respectively, with an

194 e episode in Boston MSA based on 16 years of daily observations.

195 generally outperform forecasts that utilize daily observed humidity forcing (4.4% and 2.6% respectiv

196 ociated with a significant reduction in mean daily off-time in levodopa-treated patients with PD and

197 tablets, twice daily on days 1-5, then once daily on alternate days on days 7-25) or vancomycin (125

198 vancomycin (125 mg oral capsules, four times daily on days 1-10), stratified by baseline C difficile

199 lsed fidaxomicin (200 mg oral tablets, twice daily on days 1-5, then once daily on alternate days on

200 A daily online symptom diary on both nose and eye symptoms

201 ess to palatable food was then restricted to daily operant self-administration sessions using fixed r

202 e of six tenapanor regimens (3 or 30 mg once daily or 1, 3, 10, or 30 mg twice daily) or placebo for

203 y 4 weeks with either olaparib tablets twice daily or cediranib on two schedules.

204 dine 75 mg/m(2) intravenously/subcutaneously daily or decitabine 20 mg/m(2) intravenously daily for 3

205 were randomly assigned to atorvastatin 10 mg daily or matching placebo in a randomised double-blind p

206 less to treatment with enalapril 10 mg twice daily or sacubitril/valsartan 97/103 mg twice daily (pre

207 m to continuous oral sorafenib (400 mg twice-daily) or matching placebo combined with TACE using drug

208 and cisplatin plus nintedanib (200 mg twice daily) or placebo followed by nintedanib plus placebo mo

209 30 mg once daily or 1, 3, 10, or 30 mg twice daily) or placebo for 4 weeks.

210 ive second-line oral buparlisib (100 mg once daily) or placebo, plus intravenous paclitaxel (80 mg/m(

211 ly followed by 12 weeks of 150 mg vismodegib daily) or treatment group B (150 mg oral vismodegib per

212 very 28 days), everolimus (10 mg orally once daily), or both in combination, for the core 12-month tr

213 dose (imatinib 200 mg daily, dasatinib 50 mg daily, or nilotinib 200 mg twice daily) for 12 months.

214 reduction strategy.We measured the effect of daily oral iron with or without multiple micronutrients

215 rs PrEP Study, a placebo-controlled trial of daily oral PrEP (either tenofovir monotherapy or a combi

216 and high adherence to PrEP, the efficacy of daily oral PrEP for HIV prevention did not differ signif

217 Daily oral supplementation with vitamin D3 (1000 IU) or

218 Daily oral tenofovir-based pre-exposure prophylaxis (PrE

219 Correlative evidence suggests that the daily oscillation in global protein accumulation depends

220 Procalcitonin was measured daily over the first 5 days.

221 We find significant increases in average daily peak load and overall electricity consumption in s

222 SA task varied across the day with a peak in daily performance that corresponded to the previous dail

223 ian clock systems help establish the correct daily phasing of the behavioral, developmental, and mole

224 Daily physical activity assessed by accelerometers repre

225 lly fat and sucrose, and declining levels of daily physical activity.

226 who can access, afford, and tolerate taking daily pills.

227 pated in two randomized treatment periods of daily placebo or PF-04958242 for 5 days separated by a w

228 were given the NSAID diclofenac (75 mg twice daily) plus omeprazole (20 mg once daily), and either ri

229 , the role of PET during treatment (iPET) in daily practice remains a matter of significant debate.

230 CAPT remains underused in daily practice, although it is a safe and simple procedu

231 In clinical daily practice, the standard use of the RADPAD radiation

232 drug monitoring data should be embedded into daily practice.

233 ot mean squared prediction error (RMSPE) for daily predictions are 1.78 and 2.83 mug/m(3), respective

234 aily or sacubitril/valsartan 97/103 mg twice daily (previously known as LCZ696 [200 mg twice daily])

235 existing spectral model of depth-integrated, daily production will enable efficient global prediction

236 The daily pSOFA scores and additional pediatric organ dysfun

237 ance for acute (R(2) = 0.20; P < 0.0001) and daily (R(2) = 0.23; P < 0.0001) EI.

238 control (RAMT(-)) or RAMT(+) groups (30 min daily RAMT over the stroke-affected gastrocnemius) and w

239 he signals were examined, in addition to the daily rate of epileptiform spikes, the relative power of

240 well tolerated with no adverse events.Twice daily RCE intake over 1 y potently attenuated BMD loss c

241 Simultaneously, in 2012, daily record openings increased for involuntary commitme

242 of 9652 doses taken) for women allocated the daily regimen compared with 65% for those assigned the t

243 Once daily regimens are preferred for HIV-1 treatment, to fac

244 We find that the daily rhythm in membrane excitability in the ventral SCN

245 hepatocyte size, and protein levels follow a daily rhythm, whose amplitude depends on both feeding-fa

246 cleus (SCN) of the hypothalamus orchestrates daily rhythms of physiology and behavior in mammals.

247 large cities to infer the dynamics of urban daily rhythms.

248 The once-daily, ribavirin-free, pangenotypic, direct-acting antiv

249 Strategies to reduce the daily risk of bleeding and thrombosis, and different thr

250 risk of ischemia significantly exceeded the daily risk of bleeding beyond 30 days, supporting the us

251 However, for all conditions, the adjusted daily risk of death was higher among men versus women (h

252 eeded those for ischemia within 30 days, the daily risk of ischemia significantly exceeded the daily

253 Although the association of sex with daily risk of rehospitalization varies across conditions

254 enous thromboembolism to receive either once-daily rivaroxaban (at doses of 20 mg or 10 mg) or 100 mg

255 ng at home and participating in their normal daily routines without restrictions on diet or physical

256 microbial activity and photodegradation at a daily scale.

257 Use of daily sedation interruption and a sedation/analgesia pro

258 , through safely replacing a large amount of daily sedentary time with physical activity in everyone,

259 While daily seizures are uncommon in Rett syndrome, prolonged

260 espectively.With increasing intake (for each daily serving) of whole grains (RR: 0.92; 95% CI: 0.89,

261 e studies resulting in the discovery of once daily sGC stimulator vericiguat (compound 24, BAY 102118

262 No once-daily single-tablet regimen is available for HIV-infecte

263 .62-1.86) for any dependence; and the OR for daily smoking was 2.00 (1.89-2.12).

264 Higher odds of daily smoking were observed in both cohorts for those ad

265 iciency by determining testicular histology, daily sperm production and sperm motility in knock-out a

266 d given as single morning doses versus twice-daily split dosing.

267 es, oral care, chlorhexidine mouth care, and daily spontaneous awakening and breathing trials.

268 eated patients and 103 patients who received daily St-Cp We monitored patients with standardized prot

269 ber of daily steps at day 7 was 1689 (19% of daily steps at baseline), which correlated with the Comp

270 The median number of daily steps at day 7 was 1689 (19% of daily steps at bas

271 We compared weekly versus daily steroid treatment in mouse models of acute muscle

272 Participants were randomly assigned to daily subcutaneous anakinra, 100 mg (n = 25), or placebo

273 ith fondaparinux because it does not require daily subcutaneous injection and is cheaper.

274 ad a similar safety profile to that of twice-daily subcutaneous pasireotide.

275 len-related apple allergy were randomized to daily sublingual application of placebo (n = 20) or 25 m

276 In conclusion, daily sulindac administration in FAP patients significan

277 We catalogued AEs from parental reports, daily symptom diaries, and dose escalations.

278 Daily temperatures and adverse events (AEs) were recorde

279 The daily temporal occurrence of NPF events likely caused by

280 messages about water through counseling and daily text messages, a water bottle, and a water pitcher

281 CBD or vehicle was administered daily throughout the alcohol feeding study.

282 jected 3 hours post-MI for (d)1 or continued daily till d5.

283 aseline to 8 weeks in accelerometer-measured daily time expending at least 3 METs.

284 to 11 years were randomized to receive once-daily tiotropium 5 mug (2 puffs of 2.5 mug) or 2.5 mug (

285 ted most associations, with the exception of daily tobacco smoking (adjusted OR 1.74, 95% CI 1.08-2.8

286 35 years (wave 10), mental health problems, daily tobacco smoking, illicit drug use, and dependence

287 ordinal job exposure matrix, 45% had maximum daily total hydrocarbon exposure levels >/= 1.0 ppm.

288 Daily treatment of adult male fmr1 C57Bl6 knock-out mice

289 Finally, daily treatment with the hypotonic 2-PMPA enema ameliora

290 re treated with 560 mg ibrutinib orally once daily until progression or unacceptable toxicity.

291 Mean daily walking duration and distance were not associated

292 Enasidenib 100 mg once daily was selected for the expansion phase on the basis

293 Vorinostat (100 mg twice daily) was started on day -10 and continued through day

294 erformance that corresponded to the previous daily window of food anticipation.

295 rn-type diet fed apoE(-/-) mice were treated daily with 15a or vehicle as control.

296 c PIK3CA-driven mouse mammary tumors treated daily with aspirin resulted in decreased tumor growth ki

297 ects received 40 mg or 80 mg GSK3532795 once daily with atazanavir (ATV) with or without (+/-) ritona

298 (normal vs. delirium vs. coma) was assessed daily with the Confusion Assessment Method for the ICU a

299 5 g GOS or isocaloric placebo (maltodextrin) daily with their regular meals for 12 weeks.

300 can disperse >500,000 viable seagrass seeds daily, with a maximum dispersal distance of approximatel

301 ts received oral flecainide or placebo twice daily, with the dosage guided by trough serum levels.